| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 720248 | Null | 0.024108502230778 | -0.20664556 |
| NSC 722316 | Null | 0.024108502230778 | -0.15977339 |
| NSC 732317 | 6,7-dichloro-2-methyl-3-(phenylthio)quinoxaline 1,4-dioxide | 0.024108502230778 | -0.20712143 |
| NSC 734977 | Ethyl N-[4-(10-methyl-3-phenyl-4H-indolo[3,2-e][1,2,3]triazolo [1,5-a]pyrimidin-4-yl)butanoyl]glycinate | 0.024108502230778 | 0.48774254 |
| NSC 742327 | (3-Difluoromethyl-6,7-dimethyl-1,4-dioxy-quinoxalin-2-yl)-phenyl-methanone | 0.024108502230778 | -0.16654493 |
| NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 0.024108502230778 | -0.24667641 |
| NSC 128571 | Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) | 0.0241085022307781 | -0.32712255 |
| NSC 149286 | 1,4-Pentadien-3-one, 1,5-di-3-pyridyl- | 0.0241085022307781 | -0.39439028 |
| NSC 294979 | BLEOMYCIN-BAPP | 0.0241085022307781 | 0.19167543 |
| NSC 3061 | BW 50-63 | 0.0241085022307781 | -0.22941179 |